FDRX yields 11.91% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 10
Combined, FDRX + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FDRX + PFE for your $10,000?
FDRX offers 2x the daily performance of the Founder-Led Index, which consists of 50 US publicly traded companies in which at least one original founder remains in a key executive role. The fund primarily uses derivatives, including total return swaps, equity index futures, and other equity-linked instruments, as well as direct long positions in index constituents when operationally efficient. The fund holds cash and cash equivalents for liquidity, portfolio management, and as collateral. It maintains leveraged exposure by resetting daily. As a result, performance over periods longer than one day may differ significantly from 2x the indexs cumulative return due to daily compounding and market volatility. Index constituents may be of any market capitalization but will be weighted in the portfolio by size, up to a cap of 10%. The index is reconstituted and rebalanced quarterly on the third Friday of March, June, September, and December.
Full FDRX Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.